OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Dostarlimab, Loncastuximab tesirine, & HER2 GI Updates
16 minutes
Posted May 6, 2021 at 7:57 pm.
0:00
16:37
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Two brand new drugs to discuss and their possible roles in practice. Plus, updates on the treatment of HER2-amplified gastric cancer and colorectal cancer.
Previous
A Landmark Trial (without an FDA approval)
Next
Dosing In Obesity
← See all 273 episodes of OncoPharm